Clinical trial

Influence of Nevirapine on HCV Viral Load

NCT01277627

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2011-01-01

PhaseNA

Study timeline

Study start (unknown)2011-01-01Date precision: month

Registry last updated2011-01-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HCV Infection.unresolved

HCV Viral Load.unresolved

Interventions

NevirapineDRUG · verified · RxNorm: nevirapine

efavirenz, protease inhibitorsDRUG

Sponsors & collaborators

Valme University Hospitallead sponsor

Boehringer Ingelheimcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01277627 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.